A股異動 | 新世界逼近漲停 獲股東增持逾2%的股份
格隆匯3月27日丨新世界(600628.SH)盤中觸及漲停,現報11.8元,漲幅9.26%,最新總市值76.3億。公司26日收到股東沈國軍及其一致行動人沈軍燕、沈君升、魯勝、沈瑩樂、浙江國俊有限公司發來的通知,沈國軍及其一致行動人3月19日至3月26日期間,通過證券交易系統以集中競價及大宗交易方式合計增持公司股份1347.08萬股,佔公司總股本的2.0824%。截至公告日,通過本次權益變動,沈國軍及其一致行動人合計持有公司股份由原來的3952.62萬股增加至5299.70萬股,合計佔公司總股本比例由原來的6.1103%增加至8.1928%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.